Wyeth, Nycomed Take Aim At Sandoz Over Protonix
Wyeth Pharmaceuticals Inc. and Nycomed GmbH have moved again to protect a patent for their injectable heartburn treatment Protonix, launching a lawsuit against a unit of Novartis AG that plans a...To view the full article, register now.
Already a subscriber? Click here to view full article